Understanding Epidermolysis Bullosa Acquisita (EBA)

Receiving a diagnosis of Epidermolysis Bullosa Acquisita (EBA) can feel overwhelming, especially because the name is long and the condition is exceptionally rare. Please know that EBA is an autoimmune disease—it is not contagious, it is not your fault, and its severity and course vary widely between individuals. It is natural to feel anxious when facing a disease that most people—and even many doctors—have never seen ^[1]. EBA is an autoimmune blistering disease, meaning your immune system, which normally protects you from germs, has mistakenly started attacking a specific part of your own skin ^[2].

While the name sounds similar to genetic conditions you may have researched, EBA is distinct because it is “acquired” later in life rather than inherited at birth ^[3]. This page will help you understand the biology of what is happening in your body and how this condition differs from other forms of Epidermolysis Bullosa (EB).

How EBA Differs from Inherited EB

It is critical to distinguish EBA from inherited EB (specifically dystrophic epidermolysis bullosa).

• Inherited EB is caused by genetic mutations passed down from parents or occurring at birth. In these cases, the body’s instructions for making skin proteins are “broken” from the start ^[3][4].
• EBA is an acquired condition. Most people with EBA were born with perfectly healthy skin proteins, but for reasons not yet fully understood, their immune system began producing autoantibodies—proteins that attack the skin’s structure ^[2][5].

While inherited EB usually appears in infancy or early childhood, EBA most commonly begins in adulthood. In some large patient databases, the median age of diagnosis is around 72, though it can occur in children in rare cases ^[6][7].

The Biological Mechanism: A Breakdown in “Anchoring”

To understand EBA, it helps to think of your skin as two layers—the epidermis (top) and the dermis (bottom)—that must be tightly velcroed together.

Type VII Collagen (COL7)

The “velcro” that holds these layers together is made of anchoring fibrils. These fibrils are primarily composed of a protein called Type VII collagen (COL7) ^[8]. In a healthy body, these fibrils reach from the dermis up into the epidermis to ensure the skin remains strong and resistant to friction.

The Autoimmune Attack

In EBA, your immune system produces antibodies that specifically target and latch onto this COL7 ^[2]. This triggers an inflammatory response:

1. Antibody Binding: The autoantibodies stick to the anchoring fibrils ^[9].
2. Inflammatory Recruitment: This “red flag” signals white blood cells, specifically neutrophils, to rush to the area ^[8][10].
3. Tissue Damage: These cells release enzymes and reactive molecules that chew away at the anchoring fibrils ^[9].
4. Blister Formation: Without the “velcro” of the anchoring fibrils, the top and bottom layers of skin slide apart, and fluid fills the gap, creating a subepidermal blister (a blister formed beneath the top layer of skin) ^[2][11].

Forms of the Disease

EBA is a clinical spectrum and does not look the same for everyone. Doctors generally classify it into two main clinical patterns, though mucosal-dominant, Brunsting-Perry-like, and IgA-associated variants also exist:

• Mechanobullous (Classical) EBA: This type is characterized by skin fragility. Blisters often form in response to minor trauma or friction—such as on the hands, elbows, or knees ^[12]. These blisters typically heal with scarring and small white bumps called milia ^[11].
• Inflammatory EBA: This type can look very similar to other blistering diseases like bullous pemphigoid. The skin may be red, itchy, and covered in widespread blisters that are not necessarily triggered by injury ^[10][11].

In some cases, EBA can also affect the mucous membranes, such as the inside of the mouth, the eyes, or the esophagus ^[13]. If these areas are involved, it is important to have them monitored closely, as they can develop scarring that affects function ^[14].

Rarity and Associated Conditions

EBA is considered an “orphan” disease because it is so rare. In large studies of patients with blistering diseases, EBA cases typically make up only about 2% of the total ^[1]. Because it is so uncommon, it can sometimes take time to reach a definitive diagnosis using specialized tests like direct immunofluorescence or ELISA blood tests ^[15][16].

Medical research has noted that some people with EBA also have inflammatory bowel disease (IBD), such as Crohn’s disease or ulcerative colitis ^[17]. This association is uncommon and EBA does not cause IBD, nor does every patient require routine testing. However, if you experience persistent diarrhea, unexplained weight loss, or abdominal pain, it is important to share this with your dermatology team so they can coordinate care with a gastroenterologist ^[17][18].